MPO and Parkinson disease: Recently, a small molecule inhibitor of MPO (AZD3241) was shown to be safe and tolerable in healthy adults and patients with Parkinson’s disease (Posener et al., 2014) and is currently under clinical investigation for the treatment of Multiple System Atrophy.